Article
Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells
16 May 2019
Abstract excerpt
Cancer stem cells (CSCs) residing in colorectal cancer tissues have tumorigenic capacity and contribute to chemotherapeutic resistance and disease relapse. It is well known that the survival of colorectal CSCs after 5-fluorouracil (5-FU)-based therapy leads to cancer recurrence. Thus CSCs represent a promising drug target. Here, we designed and synthesized novel hybrid molecules linking 5-FU with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
